Wortmannin-enhanced X-ray-induced apoptosis of human T-cell leukemia MOLT-4 cells possibly through the JNK/SAPK pathway

Radiation Research

Volumn 160, Issue 4, 2003, Pages 467-477

  Tomita, Masanori ^a   Suzuki, Norio ^a,b,c,d   Matsumoto, Yoshihisa ^a   Enomoto, Atsushi ^a   Yin, Hong Lan ^a   Hosoi, Yoshio ^a   Hirano, Kazuya ^a,e   Sakai, Kazuo ^a,f  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^f CENTRAL RESEARCH INSTITUTE OF ELECTRIC POWER INDUSTRY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; ATM PROTEIN; BENZYLOXYCARBONYLPHENYLALANYLALANYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; CERAMIDE; INHIBITOR OF APOPTOSIS PROTEIN; JANUS KINASE; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P21; PROTEIN P53; SERINE; STRESS ACTIVATED PROTEIN KINASE; WORTMANNIN;

APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY; T CELL LEUKEMIA; X RAY;

ANDROSTADIENES; APOPTOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LEUKEMIA, T-CELL; MITOGEN-ACTIVATED PROTEIN KINASES; RADIATION TOLERANCE; TUMOR CELLS, CULTURED; X-RAYS;

EID: 0141652967     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3055     Document Type: Article

References (44)

1. J. Minowada, T. Ohmura and G. E. Moore, Rosette-forming human lymphoid cell lines. 1. Establishment and evidence for origin of thymus-derived lymphocytes. J. Natl. Cancer Inst. 49, 891-895 (1972).
2. K. Shinohara and H. Nakano, Interphase death and reproductive death in X-irradiated MOLT-4 cells. Radiat. Res. 135, 197-205 (1993).
3. Y. Matsumoto, N. Suzuki, K. Sakai, A. Morimatsu, K. Hirano and H. Murofushi, A possible mechanism for hyperthermic radiosensitization mediated through hyperthermic lability of Ku subunits in DNA-dependent protein kinase. Biochem. Biophys. Res. Commun. 234, 568-572 (1997).
4. H. Nakano and K. Shinohara, Correlation between unirradiated cell TP53 protein levels and radiosensitivity in MOLT-4 cells. Radiat. Res. 151, 686-693 (1999).
5. Y. Matsumoto, N. Suzuki, N. Namba, N. Umeda, X-J. Ma, A. Morita, M. Tomita, A. Enomoto, S. Serizawa and Y. Hosoi, Cleavage and phosphorylation of XRCC4 protein induced by X-irradiation. FEBS Lett. 478, 67-71 (2000).
6. A. Morita, N. Suzuki, Y. Matsumoto, K. Hirano, A. Enomoto, J. Zhu and K. Sakai, p41 as a possible marker for cell death is generated by caspase cleavage of p42/SETβ in irradiated MOLT-4 cells. Biochem. Biophys. Res. Commun. 278, 627-632 (2000).
7. A. Enomoto, N. Suzuki, K. Hirano, Y. Matsumoto, A. Morita, K. Sakai and H. Koyama, Involvement of SAPK/JNK pathway in X-ray-induced rapid cell death of human T-cell leukemia cell line MOLT-4. Cancer Lett. 155, 137-144 (2000).
8. M. Tomita, N. Suzuki, Y. Matsumoto, K. Hirano, N. Umeda and K. Sakai, Sensitization by wortmannin of heat- or X-ray-induced cell death in cultured Chinese hamster V79 cells. J. Radiat. Res. 41, 93-102 (2000).
9. B. D. Price and M. B. Youmell, The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage. Cancer Res. 56, 246-250 (1996).
10. S. Boulton, S. Kyle, L. Yalcintepe and B. W. Durkacz, Wortmannin is a potent inhibitor of DNA double strand break but not single strand break repair in Chinese hamster ovary cells. Carcinogenesis 17, 2285-2290 (1996).
11. 2-M delay. Clin. Cancer Res. 3, 1149-1156 (1997).
12. R. Okayasu, K. Suetomi and R. L. Ullrich, Wortmannin inhibits repair of DNA double-strand breaks in irradiated normal human cells. Radiat. Res. 149, 440-445 (1998).
13. Y. Hosoi, H. Miyachi, Y. Matsumoto, H. Ikehata, J. Komura, K. Ishii, H-J. Zhao, M. Yoshida, Y. Takai and T. Ono, A phosphatidylinositol 3-kinase inhibitor wortmannin induces radioresistant DNA synthesis and sensitizes cells to bleomycin and ionizing radiation. Int. J. Cancer. 78, 642-647 (1998).
14. J. N. Sarkaria, R. S. Tibbetts, E. C. Busby, A. P. Kennedy, D. E. Hill and R. T. Abraham, Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. Cancer Res. 58, 4375-4382 (1998).
15. S. B. Chernikova, R. L. Wells and M. M. Elkind, Wortmannin sensitizes mammalian cells to radiation by inhibiting the DNA-dependent protein kinase-mediated rejoining of double-strand breaks. Radiat. Res. 151, 159-166 (1999).
16. V. Cryns and J. Yuan, Proteases to die for. Genes Dev. 12, 1551-1570 (1998).
17. A. Gross, J. M. McDonnell and S. J. Korsmeyer, BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13, 1899-1911 (1999).
18. G. S. Jimenez, F. Bryntesson, M. I. Torres-Arzayus, A. Priestley, M. Beeche, S. Saito, K. Sakaguchi, E. Appella, P. A. Jeggo and M. Hubank, DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage. Nature 400, 81-83 (1999).
19. E. H-Y. Cheng, D. G. Kirsch, R. J. Clem, R. Ravi, M. B. Kastan, A. Bedi, K. Ueno and J. M. Hardwick, Conversion of Bcl-2 to a Bax-like death effecter by caspases. Science 278, 1966-1968 (1997).
20. S. R. Datta, A. Brunet and M. E. Greenberg, Cellular survival: a play in three Akts. Genes Dev. 13, 2905-2927 (1999).
21. O. Inanami, K. Takahashi and M. Kuwabara, Attenuation of caspase-3-dependent apoptosis by Trolox post-treatment of X-irradiated MOLT-4 cells. Int. J. Radiat. Biol. 75, 155-163 (1999).
22. R. C. Stein and M. D. Waterfield, PI3-kinase inhibition: a target for drug development? Mol. Med. Today 6, 347-357 (2000).
23. D. R. Alessi, M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen and B. A. Hemmings, Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541-6551 (1996).
24. A-L. Mathieu, S. Gonin, Y. Leverrier, B. Blanquier, J. Thomas, C. Dantin, G. Martin, G. Baverel and J. Marvel, Activation of the phosphatidylinositol 3-kinase/Akt pathway protects against interleukin-3 starvation but not DNA damage-induced cell death. J. Biol. Chem. 276, 10935-10942 (2001).
25. F. Tsuruta, N. Masuyama and Y. Gotoh, The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. J. Biol. Chem. 277, 14040-14047 (2002).
26. V. Levresse, L. Butterfield, E. Zentrich and L. E. Heasley, Akt negatively regulates the cJun N-terminal kinase pathway in PC12 cells. J. Neurosci. Res. 62, 799-808 (2000).
27. H. Nakano, M. Kohara and K. Shinohara, Evaluation of the relative contribution of p53-mediated pathway in X-ray-induced apoptosis in human leukemic MOLT-4 cells by transfection with a mutant p53 gene at different expression levels. Cell Tissue Res. 306, 101-106 (2001).
28. M. F. Lavin and K. K. Khanna, ATM: The protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia. Int. J. Radiat. Biol. 75, 1201-1214 (1999).
29. J. C. Ghosh, K. Suzuki, S. Kodama and M. Watanabe, Effects of protein kinase inhibitors on the accumulation kinetics of p53 protein in normal human embryo cells following X-irradiation. J. Radiat. Res. 40, 23-37 (1999).
30. Y. T. Ip and R. J. Davis, Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr. Opin. Cell. Biol. 10, 205-219 (1998).
31. R. J. Davis, Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252 (2000).
32. C. Tournier, P. Hess, D. D. Yang, J. Xu, T. K. Turner, A. Nimnual, D. Bar-Sagi, S. N. Jones, R. A. Flavell and R. J. Davis, Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288, 870-874 (2000).
33. M. S. Meyn, Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res. 55, 5991-6001 (1995).
34. E. Duchanud, A. Ridet, D. Stoppa-Lyonnet, N. Janin, E. Moustacchi and F. Rosselli, Deregulated apoptosis in ataxia telangiectasia: Association with clinical stigmata and radiosensitivity. Cancer Res. 56, 1400-1404 (1996).
35. T. D. Shafman, A. Saleem, J. Kyriakis, R. Weichselbaum, S. Kharbanda and D. W. Kufe, Defective induction of stress-activated protein kinase activity in ataxia-telangiectasia cells exposed to ionizing radiation. Cancer Res. 55, 3242-3245 (1995).
36. S. Kharbanda, Z-M. Yuan, R. Weichselbaum and D. Kufe, Determination of cell fate by c-Abl activation in the response to DNA damage. Oncogene 17, 3309-3318 (1998).
37. D. P. Harkin, J. M. Bean, D. Miklos, Y-H. Song, V. B. Truong, C. Englert, E. C. Christians, L. W. Ellisen, S. Maheswaran and D. A. Haber, Induction of Gadd45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97, 575-586 (1999).
38. W-C. Liao, A. Haimovitz-Friedman, R. S. Persaud, M. McLoughlin, D. Ehleiter, N. Zhang, M. Gatei, M. Lavin, R. Kolesnick and Z. Fuks, Ataxia telangiectasia-mutated gene product inhibits DNA damage-induced apoptosis via ceramide synthase. J. Biol. Chem. 274, 17908-17917 (1999).
39. S. Basu and R. Kolesnick, Stress signals for apoptosis: ceramide and c-Jun kinase. Oncogene 17, 3277-3285 (1998).
40. S. Yoshimura, Y. Banno, S. Nakashima, K. Takenaka, H. Sakai, Y. Nishimura, N. Sakai, S. Shimizu, Y. Eguchi and Y. Nozawa, Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death. J. Biol. Chem. 273, 6921-6927 (1998).
41. M Sawada, S. Nakashima, Y. Banno, H. Yamakawa, K. Takenaka, J. Shinoda, Y. Nishimura, N. Sakai and Y. Nozawa, Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells. Oncogene 19, 3508-3520 (2000).
42. D. Tang, H. Okada, J. Ruland, L. Liu, V. Stambolic, T. W. Mak and A. J. Ingram, Akt is activated in response to an apoptotic signal. J. Biol. Chem. 276, 30461-30466 (2001).
43. S. Wang, M. Guo, H. Ouyang, X. Li, C. Cordon-Cardo, A. Kurimasa, D. J. Chen, Z. Fuks, C. C. Ling and G. C. Li, The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest. Proc. Natl. Acad. Sci. USA 97, 1584-1588 (2000).
44. N. Mori, Y. Matsumoto, M. Okumoto, N. Suzuki and J. Yamate, Variations in Prkdc encoding the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) and susceptibility to radiation-induced apoptosis and lymphomagenesis. Oncogene 20, 3609-3619 (2001).